Post by Donic Chien-Sheng Lu

Precision at the Forefront: Redefining Preclinical R&D with BioLASCO It was an honor to engage in a profound dialogue with the senior experts at BioLASCO. Our collaboration has solidified a key strategic vision: Organ-on-a-Chip (OoC) technology is not a replacement for animal testing, but a powerful "Decision Engine" that makes animal studies more accurate and purposeful. By integrating Anivance AI's innovative platform early in the R&D phase, we provide critical data to de-risk "Go/No-Go" decisions. This upfront insight minimizes unexpected deviations in subsequent animal models and ultimately paves a smoother path toward clinical success. Grateful to the BioLASCO team for aligning with this vision. In 2026, we look forward to expanding the market together, delivering highly efficient and future-ready solutions to the global drug development community. #AnivanceAI #BioLASCO #OrganOnAChip #DrugDevelopment #PrecisionMedicine #PreclinicalOptimization #BiotechPartnership